BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Clinical & Diagnostic

ZEISS and Boehringer Ingelheim Collaborate on Early Eye Disease Detection to Prevent Vision Loss.

The partnership brings together their leading expertise in ophthalmological technology, data analytics, algorithms and the development of first-in-class tr...

October 03, 2023 | News

Bausch + Lomb Completes Acquisition of XIIDRA®

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, announced it h...

October 02, 2023 | News

PHC and JCR Pharma Release Second Update for "Meron Diary" Growth Hormone Treatment App

Jointly developed by PHC IVD and JCR Pharma and released for the first time in October 2020, "Meron Diary" is a smartphone application that can wirelessly ...

October 02, 2023 | News

Rimegepant Now Available in Hong Kong as First Asian Market for Migraine Management

"As the first market in Asia, we are pleased to bring to Hong Kong this medication for migraine, as we understand how migraine can adversely...

October 02, 2023 | News

BioCity and AstraZeneca Collaborate on Hepatocellular Carcinoma Treatment in China

BioCity will lead the trial, which has received IND approval by the National Medical Products Administration (NMPA). The study will be conducted at Zhongsh...

September 28, 2023 | News

Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design

Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years and speed time to initial results while preserving the 36-week design...

September 27, 2023 | News

Bayer Indonesia launches "Bayer For Her" to improve the reproductive health of Indonesian women English

Coinciding with the commemoration of World Contraception Day 2023, Bayer Indonesia launched the "Bayer for Her" campaign, underscoring the i...

September 27, 2023 | News

Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience

Agilent Technologies, Inc. (NYSE: A) and Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, announced ...

September 26, 2023 | News

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

"We're thrilled to strengthen our existing suite of patents," said Peter Choo, Chairman of CytoMed. "Now this novel iPSC-based technology has been gra...

September 26, 2023 | News

Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients

Many lung cancer patients are grappling with a multitude of symptoms throughout their treatment process, including but not limited to fatigue, reduced appe...

September 26, 2023 | News

MediLink Therapeutics Focuses on Advancing ADCs for Cancer Treatment

On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered in Guangzhou to ...

September 25, 2023 | News

AstraZeneca and Institut Kanser Negara Collaborate to Introduce AI Lung Screening in Malaysia

In conjunction with Institut Kanser Negara's (IKN) 10th anniversary, AstraZeneca announced its collaboration to accelerate digitalisati...

September 25, 2023 | News

Inmagene Forms Celexor Bio with Enhanced anti-ILT7 mAb

"We are pleased to partner with Aditum Bio, a highly innovative venture capital firm established by pharma industry leaders with deep drug development expe...

September 22, 2023 | News

China's NMPA Recommends Priority Review for Cefepime-Taniborbactam in UTI Treatment

"Currently, the clinical challenges from multi-drug resistant infections are severe. The recommendation of priority review by CDE for cefepime-taniborbacta...

September 20, 2023 | News

Stay Connected